Michelle Bragazzi, BS, RN | Authors

April 24, 2017

Younger cancer survivors experience worse survival outcomes following a second primary cancer diagnosis than their older counterparts, according to a recent study.

May 06, 2016

Advanced practice nurses and oncology nurses can benefit from having a better understanding of recently approved immunotherapies and targeted agents, both in how they work and who should be receiving them.

May 03, 2016

May 02, 2016

While oncologic emergencies are common among cancer patients, they can often be avoided with close monitoring, early intervention, and ongoing patient education.

May 01, 2015

Understanding treatment-induced neurotoxicity can be difficult when treating patients with central nervous system (CNS) malignancies.

April 28, 2015

This session at ONS reviewed treatment options for CLL and the issues associated with bone marrow transplantation in eligible patients.

April 27, 2015

The topic of obesity and its effect on cancer risk and subsequent treatment was discussed in detail at this year's Oncology Nursing Society annual meeting in Orlando, Florida.

April 27, 2015

Patients with lung cancer are increasingly receiving targeted therapies that induce complete disease remissions, but they can also develop resistance to these drugs. New efforts are now underway to discover and develop new options for patients experiencing drug resistance.

May 09, 2014

New treatment options for melanoma continue to be developed, especially in the areas of immunotherapies and targeted agents. Oncology nurses need to be knowledgeable about the various therapies being used, indication for use, and the management of adverse events.

May 09, 2014

Oncolytic viruses are receiving more attention these days as a form of cancer treatment, and have shown promise in clinical trials. These viruses are thought not only to cause direct destruction of the tumor cells, but also to stimulate a patient's immune response.